China Medical System Performance
CHSYFDelisted Stock | USD 0.93 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and China Medical are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days China Medical System has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, China Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow | 2.7 B | |
Total Cashflows From Investing Activities | -1.5 B | |
Free Cash Flow | 2.5 B |
China |
China Medical Relative Risk vs. Return Landscape
If you would invest 93.00 in China Medical System on September 2, 2024 and sell it today you would earn a total of 0.00 from holding China Medical System or generate 0.0% return on investment over 90 days. China Medical System is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than China, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
China Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for China Medical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as China Medical System, and traders can use it to determine the average amount a China Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
CHSYF |
Based on monthly moving average China Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of China Medical by adding China Medical to a well-diversified portfolio.
China Medical Fundamentals Growth
China Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of China Medical, and China Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on China Pink Sheet performance.
Return On Equity | 0.24 | |||
Return On Asset | 0.13 | |||
Profit Margin | 0.36 % | |||
Operating Margin | 0.37 % | |||
Current Valuation | 3.84 B | |||
Shares Outstanding | 2.45 B | |||
Price To Earning | 8.10 X | |||
Price To Book | 1.71 X | |||
Price To Sales | 0.45 X | |||
Revenue | 8.34 B | |||
EBITDA | 3.48 B | |||
Cash And Equivalents | 5.25 B | |||
Cash Per Share | 2.14 X | |||
Total Debt | 573.81 M | |||
Debt To Equity | 0.13 % | |||
Book Value Per Share | 5.64 X | |||
Cash Flow From Operations | 2.49 B | |||
Earnings Per Share | 0.19 X | |||
Total Asset | 15.81 B | |||
About China Medical Performance
By analyzing China Medical's fundamental ratios, stakeholders can gain valuable insights into China Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if China Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if China Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the Peoples Republic of China. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited. China Medical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5454 people.Things to note about China Medical System performance evaluation
Checking the ongoing alerts about China Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for China Medical System help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.China Medical System is not yet fully synchronised with the market data | |
China Medical System has some characteristics of a very speculative penny stock | |
China Medical System has a very high chance of going through financial distress in the upcoming years | |
About 50.0% of the company shares are held by company insiders |
- Analyzing China Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether China Medical's stock is overvalued or undervalued compared to its peers.
- Examining China Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating China Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of China Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of China Medical's pink sheet. These opinions can provide insight into China Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in China Pink Sheet
If you are still planning to invest in China Medical System check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Medical's history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |